Clinical Trial: A Trial to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Spontaneous Urticaria

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875426) titled 'A Trial to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Spontaneous Urticaria' on Sept. 24.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AK139 injection in patients with chronic spontaneous urticaria (CSU) receiving background treatment with H1-antihistamines (H1-AHs).

Study Start Date: Oct. 21

Study Type: INTERVENTIONAL

Condition: Chronic Spontaneous Urticaria

Intervention: BIOLOGICAL: AK139

AK139 administered subcutaneously

BIOLOGICAL: Placebo

Placebo administered subcutaneously

Recruitment...